Revvity Total Current Assets 2010-2024 | RVTY

Revvity total current assets from 2010 to 2024. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
  • Revvity total current assets for the quarter ending June 30, 2024 were $3.159B, a 10.35% decline year-over-year.
  • Revvity total current assets for 2023 were $3.001B, a 8.74% decline from 2022.
  • Revvity total current assets for 2022 were $3.289B, a 34.73% increase from 2021.
  • Revvity total current assets for 2021 were $2.441B, a 9.02% increase from 2020.
Revvity Annual Total Current Assets
(Millions of US $)
2023 $3,001
2022 $3,289
2021 $2,441
2020 $2,239
2019 $1,374
2018 $1,235
2017 $1,200
2016 $1,190
2015 $1,033
2014 $1,069
2013 $1,045
2012 $972
2011 $883
2010 $1,085
2009 $884
Revvity Quarterly Total Current Assets
(Millions of US $)
2024-06-30 $3,159
2024-03-31 $3,059
2023-12-31 $3,001
2023-09-30 $2,913
2023-06-30 $3,523
2023-03-31 $3,796
2022-12-31 $3,289
2022-09-30 $3,116
2022-06-30 $2,108
2022-03-31 $2,455
2021-12-31 $2,441
2021-09-30 $2,251
2021-06-30 $2,260
2021-03-31 $2,675
2020-12-31 $2,239
2020-09-30 $1,676
2020-06-30 $1,531
2020-03-31 $1,342
2019-12-31 $1,374
2019-09-30 $1,548
2019-06-30 $1,338
2019-03-31 $1,248
2018-12-31 $1,235
2018-09-30 $1,165
2018-06-30 $1,202
2018-03-31 $1,234
2017-12-31 $1,200
2017-09-30 $1,546
2017-06-30 $1,434
2017-03-31 $1,117
2016-12-31 $1,190
2016-09-30 $1,154
2016-06-30 $1,079
2016-03-31 $1,050
2015-12-31 $1,033
2015-09-30 $1,074
2015-06-30 $1,070
2015-03-31 $1,023
2014-12-31 $1,069
2014-09-30 $1,074
2014-06-30 $1,081
2014-03-31 $1,098
2013-12-31 $1,045
2013-09-30 $948
2013-06-30 $907
2013-03-31 $897
2012-12-31 $972
2012-09-30 $941
2012-06-30 $898
2012-03-31 $908
2011-12-31 $883
2011-09-30 $930
2011-06-30 $1,076
2011-03-31 $1,088
2010-12-31 $1,085
2010-09-30 $978
2010-06-30 $924
2010-03-31 $891
2009-12-31 $884
2009-09-30 $851
2009-06-30 $820
2009-03-31 $781
Sector Industry Market Cap Revenue
Medical Medical Services $14.682B $2.751B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $98.658B 12.24
Cencora (COR) United States $49.082B 18.10
DiDi Global (DIDIY) China $23.427B 0.00
ICON (ICLR) Ireland $17.504B 15.59
Natera (NTRA) United States $16.570B 0.00
Viatris (VTRS) United States $15.624B 4.81
Avantor (AVTR) United States $15.178B 22.75
BioMerieux (BMXMF) France $13.087B 0.00
CochLear (CHEOY) Australia $12.998B 0.00
Solventum (SOLV) United States $12.357B 0.00
Doximity (DOCS) United States $11.372B 67.31
Medpace Holdings (MEDP) United States $11.301B 31.84
Charles River Laboratories (CRL) United States $11.285B 21.81
HealthEquity (HQY) United States $8.756B 47.52
Sonic Healthcare (SKHHY) Australia $8.590B 0.00
Bausch + Lomb (BLCO) Canada $7.202B 33.53
Life Times (LTH) United States $5.139B 34.01
Sotera Health (SHC) United States $4.509B 24.12
Organon (OGN) United States $4.144B 4.18
Surgery Partners (SGRY) United States $3.996B 44.27
BrightSpring Health Services (BTSG) United States $3.489B 74.22
PACS (PACS) United States $3.347B 0.00
Alignment Healthcare (ALHC) United States $2.580B 0.00
Concentras Parent (CON) United States $2.505B 0.00
Ardent Health Partners (ARDT) United States $2.471B 0.00
Premier (PINC) United States $2.314B 11.55
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $2.016B 0.00
GoodRx Holdings (GDRX) United States $1.856B 48.90
Teladoc Health (TDOC) United States $1.689B 0.00
Progyny (PGNY) United States $1.540B 27.08
Pediatrix Medical (MD) United States $1.371B 13.41
Establishment Labs Holdings (ESTA) $1.266B 0.00
CareDx (CDNA) United States $1.252B 0.00
AMN Healthcare Services Inc (AMN) United States $1.058B 7.16
Embecta (EMBC) United States $0.910B 6.07
Agilon Health (AGL) United States $0.890B 0.00
InnovAge Holding (INNV) United States $0.809B 0.00
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
SBC Medicals (SBC) United States $0.723B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
Sonida Senior Living (SNDA) United States $0.459B 0.00
DocGo (DCGO) United States $0.411B 15.46
Enhabit (EHAB) United States $0.403B 34.83
COMPASS Pathways (CMPS) United Kingdom $0.363B 0.00
LifeMD (LFMD) United States $0.308B 0.00
Sera Prognostics (SERA) United States $0.248B 0.00
ModivCare (MODV) United States $0.231B 12.54
Beauty Health (SKIN) United States $0.218B 0.00
Biodesix (BDSX) United States $0.205B 0.00
Nutex Health (NUTX) United States $0.152B 0.00
MultiPlan (MPLN) United States $0.137B 0.00
Ascend Wellness Holdings (AAWH) United States $0.107B 0.00
So-Young (SY) China $0.088B 21.28
Singular Genomics Systems (OMIC) United States $0.057B 0.00
Harvard Apparatus Regenerative Technology (HRGN) United States $0.054B 0.00
OncoCyte (OCX) United States $0.049B 0.00
NeueHealth (NEUE) United States $0.042B 1.10
Co-Diagnostics (CODX) United States $0.038B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.028B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
Oncology Institute (TOI) United States $0.020B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
XWELL (XWEL) United States $0.009B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00